Altamira Therapeutics
Altamira Therapeutics focuses on developing innovative pharmaceutical therapies to protect hearing, silence tinnitus, and restore balance. It is pioneering treatments for neurotologic disorders affecting the inner ear.
Top Stages
1 past transactions
Trasir Therapeutics
Acquisition in 2021
Trasir Therapeutics is a pioneering biotechnology company specializing in extrahepatic oligonucleotide delivery, allowing for the targeted delivery of short interfering RNA (siRNA) and other RNA-based therapeutics to locations outside the liver. The firm is dedicated to developing RNA therapeutics aimed at addressing diseases characterized by various inflammatory mechanisms. While Trasir Therapeutics has programs across several therapeutic areas, its initial focus is on utilizing siRNAs to create innovative treatment strategies for cancer, positioning itself as a key player in the advancement of cancer therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.